Biogen's injectable pen for Avonex receives FDA approval

02/28/2012 | Boston Globe (tiered subscription model), The

The FDA approved Biogen Idec's user-friendly injectable pen for delivering Avonex, a multiple sclerosis drug. Biogen also obtained approval for a dosing schedule intended to relieve flu-like symptoms normally associated with Avonex.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC